Effect of Haridra arka in Type 2 Diabetes mellitus
Phase 2
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/08/056758
- Lead Sponsor
- Sariga S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants fulfilling the diagnostic criteria
Participants diagnosed with Type 2 Diabetes mellitus within 2 years.
Participants willing to sign the informed consent form.
Participants having any or both the blood glucose levels with following ranges
FBS - 126mg/dl to 250mg/dl
PPBS- 200mg/dl to 350mg/dl
Exclusion Criteria
Participants diagnosed with Type 1 Diabetes mellitus.
Participants with secondary diabetes.
Participants who are known cases of other systemic illness.
Type 2 Diabetes mellitus patients with complications.
Participants who are known cases of psychiatric illness.
Pregnant and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. FBS <br/ ><br>2. PPBSTimepoint: Assessment on 15th & 31st day with intervention <br/ ><br>and 45th day without intervention
- Secondary Outcome Measures
Name Time Method 1. Polyuria <br/ ><br>2. Polyphagia <br/ ><br>3. Polydipsia <br/ ><br>4. Excessive Sweating <br/ ><br>5. FatigueTimepoint: Assessment on 15th & 31st day with intervention <br/ ><br>and 45th day without intervention;Quality of LifeTimepoint: 30 days